p-chlorophenylalanine-induced serotonin depletion: reduction in exploratory locomotion but no obvious sensory-motor deficits

Behavioural Brain Research
H C DringenbergC H Vanderwolf

Abstract

Para-chlorophenylalanine (PCPA) depletes central serotonin (5-hydroxytryptamine, 5-HT) by inhibiting tryptophan hydroxylase, an enzyme necessary for the synthesis of 5-HT. The effects of a wide range of PCPA doses (150-1000 mg/kg) on spontaneous exploratory locomotor activity in a novel environment, activity in running wheels and a number of sensory-motor capacities were examined. Administration of 1000 mg/kg PCPA reduced whole brain levels of 5-HT and its metabolite 5-hydroxyindoleacetic acid to 9.4 and 8.2% of control levels, respectively. Treatment with PCPA produced a dose-dependent decrease in exploratory locomotion in an unfamiliar automated open field relative to vehicle-treated animals. Further, all measures of general, horizontal and vertical activity were suppressed by PCPA treatment. In contrast to previous work, hyperactivity of rats chronically housed in cages with running wheel access was not observed. In their home cages, some PCPA-treated rats exhibited hyper-reactivity to cutaneous stimulation. No other sensory-motor deficits were apparent. Previous theories of 5-HT function state that its action may be to inhibit motor activity or promote sleep. The present results challenge this view and suggest that 5-HT, at...Continue Reading

References

Mar 1, 1976·Neuropharmacology·C A Marsden, G Curzon
Jul 1, 1976·Physiology & Behavior·S Capobianco, L W Hamilton
Dec 1, 1992·Pharmacology, Biochemistry, and Behavior·B K LipskaD R Weinberger
Jan 1, 1990·Annals of the New York Academy of Sciences·C H VanderwolfC Dickson
Jan 1, 1990·Annals of the New York Academy of Sciences·D P Taylor
Jan 1, 1990·Annals of the New York Academy of Sciences·D S CharneyG R Heninger
Jan 1, 1990·Annals of the New York Academy of Sciences·I Törk
Sep 1, 1989·Behavioural Brain Research·D Eilam, I Golani
Mar 1, 1986·Pharmacology, Biochemistry, and Behavior·A S EisonL A Riblet
Jan 1, 1971·Neuropharmacology·H C Fibiger, B A Campbell
Apr 1, 1970·Physiology & Behavior·J A Rosecrans
Jan 1, 1970·Journal of Comparative and Physiological Psychology·G S Lynch
Sep 1, 1993·Trends in Neurosciences·B L Jacobs, C A Fornal
Jan 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·T E RobinsonI Q Whishaw
Jun 1, 1960·Canadian Journal of Psychology·H J CLAUS, D BINDRA

❮ Previous
Next ❯

Citations

Oct 5, 2006·Psychopharmacology·Q David WalkerCynthia M Kuhn
May 18, 2013·Psychopharmacology·Jakob NäslundElias Eriksson
Feb 26, 2003·European Journal of Pharmacology·Laetitia Prut, Catherine Belzung
Dec 20, 1999·Behavioural Brain Research·J FrohlichD Pfaff
Oct 13, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M W Gittos, M Papp
Jan 20, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·N UçeylerC Sommer
Aug 5, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nicolas Narboux-NêmeRaymond Mongeau
Jul 27, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Laura KentonDonald P Cain
Dec 20, 2012·American Journal of Physiology. Endocrinology and Metabolism·Anna CoppolaChristopher B Newgard
Jan 19, 2016·Frontiers in Behavioral Neuroscience·Susanne NikolausHans-Wilhelm Müller
Jun 2, 2012·Behavioural Brain Research·Alicia IzquierdoFeimeng Zhou
Aug 12, 2010·Behavioural Brain Research·S TejadaS Esteban
Jun 24, 2015·Behavioural Brain Research·Akiyoshi SaitohMitsuhiko Yamada
Jan 24, 2015·The International Journal of Neuropsychopharmacology·Masanori OokuboHirohiko Kanai
Aug 4, 2007·Neurochemistry International·Marit A C TankeJakob Korf
Jan 8, 2015·Frontiers in Behavioral Neuroscience·Susanne NikolausHans-Wilhelm Müller
May 9, 2006·Behavioural Brain Research·Ian Q WhishawHugo Lehmann
Jun 20, 2008·Journal of Psychopharmacology·T C ArdisS J Cooper
Mar 22, 2020·International Journal of Molecular Sciences·Irina B DeryabinaKhalil L Gainutdinov
Feb 18, 2021·Acta Neuropsychiatrica·S Melker HagsäterElias Eriksson
Aug 12, 2021·Reviews in the Neurosciences·Susanne NikolausHans-Wilhelm Müller
Aug 28, 2021·Biomedicines·Ji Hwan Lee, Woojin Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.